SCHEMBL25337533

SCHEMBL25337533

COC(=O)c1cnn2ccc(C(=O)C=CN(C)C)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.45
▸ LMNA P02545 4/20 0.45
▸ ALDH1A1 P00352 7/20 0.42
▸ RAB9A P51151 5/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HTT P42858 4/20 0.42
▸ GAA P10253 2/20 0.42
▸ HPGD P15428 3/20 0.42
▸ RECQL P46063 2/20 0.40
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ EPHB3 P54753 2/20 0.38
▸ POLB P06746 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26352696 1.00 MAPT (0.45) MAPTLMNAALDH1A1RAB9ANPC1
SCHEMBL19786566 0.82 EPHB3 (0.44) MAPTLMNAALDH1A1RAB9ANPC1
SCHEMBL2176212 0.80 NPC1 (0.49) MAPTLMNAALDH1A1RAB9ANPC1
SCHEMBL17320982 0.74 EPHB3 (0.56) MAPTLMNAALDH1A1RAB9ANPC1
SCHEMBL3612196 0.74 CA12 (0.46) MAPTLMNAEPHB3KMT2A
SCHEMBL5030728 0.74 TGFBR1 (0.45) MAPTLMNAALDH1A1SMN1; SMN2GAA
SCHEMBL3643070 0.73 SMN1; SMN2 (0.44) MAPTALDH1A1RAB9ASMN1; SMN2HTT
SCHEMBL25336177 0.73 EPHB3 (0.44) MAPTLMNAALDH1A1HTTGAA
SCHEMBL3612887 0.73 EPHB3 (0.61) MAPTLMNAALDH1A1CYP1A2CYP2C19
SCHEMBL12689690 0.72 SMN1; SMN2 (0.47) MAPTLMNAALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303562-A1 PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-09-28 — — US disclosed
EP-4219453-A1 PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2023-08-02 — — EP disclosed
WO-2022063050-A1 PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303562-A1 PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF CYP51A1, CYP4F11, WEE1 MAPT 4409/4885LMNA 3039/4885ALDH1A1 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback